Nippon India NIFTY Pharma ETF Growth Plan
NSE: PHARMABEES
BSE: 590142
₹23.33
as on
Nippon India NIFTY Pharma ETF Growth Plan Performance
Day's Low
Day's High
₹23.14₹23.91
0.81%
Downside
2.49%
Upside
52 Week's Low
52 Week's High
₹19.47₹24.6516.55%
Downside
5.66%
Upside
Market Stats
- Previous Close
- ₹23.33
- Open
- ₹23.91
- Upper Circuit
- ₹27.73
- Lower Circuit
- ₹18.49
Historical Returns
- 1 Month Return
- + 0.34 %
- 3 Month Return
- + 2.55 %
- 1 Year Return
- + 2.91 %
Nippon India NIFTY Pharma ETF Growth Plan Fundamentals
| Expense Ratio | 0.21% |
| Avg. PE ratio | 32.94 |
| Avg. PB ratio | 4.75 |
| AUM | ₹1,033.98 Cr. |
Companies in Nippon India NIFTY Pharma ETF Growth Plan
| Companies | 1D Returns |
 Sun Pharmaceutical Industries Ltd | 0.76 |
 Cipla Ltd | 0.34 |
 Divis Laboratories Ltd | 0.05 |
 Dr Reddys Laboratories Ltd | 0.46 |
 Lupin Ltd | 1.54 |
Portfolio Breakup
Sector
Market Cap
Insights on Nippon India NIFTY Pharma ETF Growth Plan
Insights help you understand the recent movement of the ETF's critical parameters, giving you an overall view of the ETF.
POSITIVE IMPACTPrice Rise
In the last 3 years, Nippon India NIFTY Pharma ETF Growth Plan has moved up by 80.57%
NO EFFECTAgainst Peers
In the last 1 year, Aditya Birla Sun Life NIFTY Healthcare ETF has given 3.13% return, outperforming Nippon India NIFTY Pharma ETF Growth Plan by 0.22%.
- NO EFFECT
Against Peers
In the last 3 year, Motilal Oswal S&P BSE Healthcare ETF has given 92.26% return, outperforming Nippon India NIFTY Pharma ETF Growth Plan by 11.69%.
- NO EFFECT
Market Cap Breakup
Market Cap breakup for Nippon India NIFTY Pharma ETF Growth Plan is 57.27% in LARGE CAP, 35.40% in MID CAP and 7.32% in SMALL CAP with top sector being Pharmaceuticals with 100.00%
About Nippon India NIFTY Pharma ETF Growth Plan
Owner: Nippon India Mutual Fund
Ticker: PHARMABEES
Price: ₹23.33 per unit as on 12 Dec, 2025 04:01 PM
Asset Under Management AUM: ₹1,033.98Cr as of today
Expense Ratio: 0.21% as of today
| Exchange | NSE |
| E-voting on shares | Click here to vote |
FAQs on Nippon India NIFTY Pharma ETF Growth Plan
What is Nippon India NIFTY Pharma ETF Growth Plan share price today?
Nippon India NIFTY Pharma ETF Growth Plan share price today stands at ₹23.33, Open: ₹23.91, Previous Close: ₹23.33, High: ₹23.91, Low: ₹23.14, 52 Week High: ₹24.65, 52 Week Low: ₹19.47.
What are today's High and Low prices of Nippon India NIFTY Pharma ETF Growth Plan?
- Today's highest price of Nippon India NIFTY Pharma ETF Growth Plan is ₹23.91
- Today's lowest price of Nippon India NIFTY Pharma ETF Growth Plan is ₹23.14
What is the 52 Week High and Low Range of Nippon India NIFTY Pharma ETF Growth Plan?
How can I invest in Nippon India NIFTY Pharma ETF Growth Plan?
You can invest via your demat account in the Nippon India NIFTY Pharma ETF Growth Plan. You can invest either through SIP mode or lumpsum mode.
Can I invest in Nippon India NIFTY Pharma ETF Growth Plan through a Systematic Investment Plan (SIP)?
Yes. Nippon India NIFTY Pharma ETF Growth Plan is available for SIP on INDmoney platform for daily, weekly or monthly SIP.
What are the risks associated with investing in Nippon India NIFTY Pharma ETF Growth Plan?
Nippon India NIFTY Pharma ETF Growth Plan's drawbacks are not related to specifically Nippon India NIFTY Pharma ETF Growth Plan. In Indian context, some of the ETFs have a drawbacks of higher tracking, lower trading volumes, etc.
Can I use Nippon India NIFTY Pharma ETF Growth Plan as collateral for a loan?
Yes. Nippon India NIFTY Pharma ETF Growth Plan can used as collateral for a loan under Loan Against Securities.